Stellar Biotechnologies, Inc. 4
4 · Stellar Biotechnologies, Inc. · Filed Dec 21, 2016
Insider Transaction Report
Form 4
NIFFENEGGER KATHI
Chief Financial Officer
Transactions
- Award
Share Option (Right to Buy)
2016-12-20+10,000→ 10,000 totalExercise: $2.03Exp: 2023-12-20→ Common Shares (10,000 underlying)
Footnotes (1)
- [F1]Option grant under the 2013 Fixed Share Option Plan, which shall vest as to one-third immediately, as to one-third on December 20, 2017 and as to the remaining one-third on June 20, 2018.